Home

PAUL F TRUEX

CIK 1120362 · Executive Chaiman · last filed 2022-06-01

PAUL F TRUEX is an Executive Chaiman who has filed 58 SEC Form 4 insider transactions across 4 companies since 2010. The most recent filing, for MIST, was dated Jun 1, 2022. Across all open-market trades the lifetime net is −$987.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.2K

Companies

4

Total Filings

58

Lifetime Open-Market Net

-$987.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MIST Director 8,016 $1.27 $10.2K $28.0K 4 2022-06-01
CymaBay Therapeutics, Inc. (CBAY) Delisted Director — $32.48 — $0 8 2021-01-28
Anthera Pharmaceuticals Inc (ANTH) Delisted Executive Chaiman 21,801 — — -$1.03M 39 2018-01-09
Trius Therapeutics Inc (TSRX) Delisted Director 13,270 — — $17.1K 6 2013-05-23

Recent Filings

58 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-06-01 MIST Mixed +81,780 $143.8K EDGAR
2021-07-29 MIST Grant (A) — $0 EDGAR
2021-01-28 CymaBay Therapeutics, Inc. (CBAY) Delisted Grant (A) — $0 EDGAR
2020-06-08 MIST Grant (A) — $0 EDGAR
2020-05-19 CymaBay Therapeutics, Inc. (CBAY) Delisted Grant (A) — $0 EDGAR
2019-11-14 MIST Grant (A) — $0 EDGAR
2019-01-31 CymaBay Therapeutics, Inc. (CBAY) Delisted Grant (A) — $0 EDGAR
2018-01-26 CymaBay Therapeutics, Inc. (CBAY) Delisted Grant (A) — $0 EDGAR
2018-01-09 Anthera Pharmaceuticals Inc (ANTH) Delisted Grant (A) — $0 EDGAR
2017-09-26 CymaBay Therapeutics, Inc. (CBAY) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 58
Page 1 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.